Le Lézard
Classified in: Science and technology
Subjects: PDT, MAT

ANYX Showcases its New Product ANYX MAX PLUS at VapeCon -The Closed Pod System Lasts Most


ANYX, a user-driven vape brand, has announced the launch of ANYX MAX PLUS at VapeCon South Africa. The patented closed pod system provides up to 8000 puffs per pod, making it the longest-lasting closed pod vape product available.

SHENZHEN, China, Aug. 31, 2023 /PRNewswire-PRWeb/ -- ANYX, a user-driven vape brand, has announced the launch of ANYX MAX PLUS at VapeCon South Africa. The patented closed pod system provides up to 8000 puffs per pod, making it the longest-lasting closed pod vape product available. Pods come in two nicotine strength options - 2% and 5% - to suit different consumer preferences.

Its flexible structure ensures durability for extended usage, making it a perfect companion to experience the remarkable 8000 puffs and immerse in the world where flavors, satisfaction, and innovation converge.

STRIPED LED, DURABLE STYLING

Featuring a distinctive and iconic striped LED design, the ANYX Max Plus boasts a stylish and sleek silhouette that exudes simplicity and trendiness. Its flexible structure ensures durability for extended usage, making it a perfect companion to experience the remarkable 8000 puffs and immerse in the world where flavors, satisfaction, and innovation converge.

SAFETY & SATISFACTION

The ANYX MAX Plus takes everything users love about the ANYX MAX and enhances it even further. It is made of food-grade PCTG material and, due to a larger capacity, ANYX improved the mesh coil, which is able to maximize the heating of e-liquid, vapors can expect excellent consistency in flavor and vapor output, even during long puffs. ANYX has also optimized the internal airflow system within ANYX MAX Plus. This enhanced airflow works synergistically with the coils to provide dense, satisfying vapor to the user.

MORE PUFFS, LESS SPENDING

Up to 8000 puffs of duration, ANYX MAX PLUS equals 30 packs of traditional cigarettes, 10 times of ordinary closed pod vapes in the market. No more constantly replacing your vape, This reusable device is a smart choice that saves you money in the long run.

FLAVORS

Providing an authentic and consistent flavor experience has always been a core focus for ANYX since the first launch of ANYX Pro, a well-known closed pod system with its iconic Sensit Coil technology. Our users have raved about the ANYX MAX's powerful performance, one of our most popular products since its release earlier this year. Now, We're excited to expand our ANYX Max Plus range with new flavors:

The new ANYX MAX Plus flavors are available now at www.anyxglobal.com

Follow our social media @ anyx global

Media Contact

MING YANG, ANYX GLOBAL, 86 13317369947, [email protected], WWW.ANYXGLOBAL.COM

SOURCE ANYX GLOBAL


These press releases may also interest you

at 07:00
In Phase Ia clinical study, GZR4 demonstrated favorable safety and tolerability profiles in healthy subjects, maintaining a stable glucose-lowering effect for up to one week with a single administration.In Phase Ib clinical study, patients with Type...

at 06:52
With cross-border trade representing a new direction for e-commerce in recent years, cross-border e-commerce in Chengdu has experienced explosive growth. Its public service platforms completed more than 61 million import and export declarations in...

at 06:26
At RE+ 2024, Sunwoda made a significant impact under the theme "Sunwoda Inside," underscoring its leadership in providing end-to-end energy storage solutions. With 27 years of experience in battery technology, Sunwoda has developed a comprehensive...

at 06:00
BioInvent International (STO:BINV)Preliminary data presented at ESMO 2024 demonstrate BT-001 induces tumor regression in patients who failed previous anti-PD(L)-1 treatmentIn a patient with a heavily pretreated leiomyosarcoma, BT-001 was able to...

at 05:18
Mox Capital, a trailblazer in alternative investments with AUM of US$1.4 billion, is announcing its strategic support for a vast array and variety of regional high-potential startups. According to COO Nguyen Dinh Giang, Mox Capital seeks to reinforce...

at 05:00
Updated Phase 1 dose-escalation data from ARROS-1 and ALKOVE-1 clinical trials continue to support potential best-in-class profiles for zidesamtinib and NVL-655 Rapid enrollment in Phase 2 portions of the ARROS-1 and ALKOVE-1 clinical trials;...



News published on and distributed by: